2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Bibliographic Details
Main Authors:	G. Hindricks, T. Potpara, N. Dagres, E. Arbelo, J. J. Bax, C. Blomstrӧm-Lundqvist, G. Boriani, M. Castella, G.-A. Dan, P. E. Dilaveris, L. Fauchier, G. Filippatos, J. M. Kalman, M. La Meir, D. A. Lane, J.-P. Lebeau, M. Lettino, G. Y.H. Lip, F. J. Pinto, G. Neil Thomas, M. Valgimigli, I. C. Van Gelder, B. P. Van Putte, C. L. Watkins
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-10-01
Series:	Российский кардиологический журнал
Subjects:	guidelines atrial fibrillation anticoagulation vitamin k antagonists non-vitamin k antagonist oral anticoagulants left atrial appendage occlusion rate control rhythm control cardioversion antiarrhythmic drugs catheter ablation pulmonary vein isolation left atrial ablation af surgery upstream therapy abc pathway screening stroke recommendations.
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4701

Similar Items

2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS
by: Paulus Kirchhof, et al.
Published: (2017-08-01)

A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation
by: Giuseppe Patti, et al.
Published: (2022-03-01)

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
by: Chern-En Chiang, et al.
Published: (2016-11-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01)

Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study
by: Pompilio Faggiano, et al.
Published: (2022-03-01)

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
by: Pedro Luis Cepas-Guillen, et al.
Published: (2021-10-01)

Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study
by: Francesco De Stefano, et al.
Published: (2022-08-01)

The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up
by: Zhu J, et al.
Published: (2021-03-01)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Anna Szpotowicz, et al.
Published: (2021-10-01)

Effect of edoxaban compared with other oral anticoagulants for stroke prevention in patients with atrial fibrillation: A meta-analysis
by: Bailin Zhang, et al.
Published: (2023-11-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
by: Song T, et al.
Published: (2021-03-01)

Oral anticoagulation – current knowlegde
by: Anna Karaś, et al.
Published: (2022-10-01)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
by: Marek Koziński, et al.
Published: (2020-06-01)

Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation
by: Zsuzsa Bagoly, et al.
Published: (2020-09-01)

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
by: Monika Kozieł, et al.
Published: (2020-06-01)

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis
by: Tabito Kino, et al.
Published: (2022-03-01)

Prevention of thromboembolic complications in patients with atrial fibrillation and obesity
by: Izabela Kolasa, et al.
Published: (2023-04-01)

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01)

Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis
by: Nso Nso, et al.
Published: (2022-06-01)

Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
by: George Ntaios, et al.
Published: (2021-03-01)

Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)
by: Benjamin A. Steinberg, et al.
Published: (2018-02-01)

Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
by: José Felipe Varona, et al.
Published: (2020-12-01)

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
by: Kang-Ling Wang, et al.
Published: (2017-08-01)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
by: Suárez Fernández C, et al.
Published: (2018-02-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
by: Simon Schwill, et al.
Published: (2018-07-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Time Trends of Etiology, Treatment, and Long-Term Outcomes Among Patients with Left Ventricular Thrombus
by: Boqun Shi, et al.
Published: (2023-10-01)

Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases
by: O. Yu. Chizhova, et al.
Published: (2018-09-01)

Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
by: Oh Young Bang, et al.
Published: (2023-05-01)

ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases
by: Uğur Önsel Türk, et al.
Published: (2020-04-01)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01)

Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population‐Based Cohort Study
by: Jin‐Yi Hsu, et al.
Published: (2021-03-01)

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
by: Maria Cristina Vedovati, et al.
Published: (2019-04-01)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
by: Shujuan Zhao, et al.
Published: (2021-06-01)

Direct oral anticoagulants in atrial fibrillation patients aged 75 years or older: Efficacy and safety balance
by: V V Fomin, et al.
Published: (2017-04-01)

Early Anticoagulation in Patients with Acute Ischemic Stroke Due to Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Lina Palaiodimou, et al.
Published: (2022-08-01)